Stock Analiz

Repligen Corp. (RGEN) stock forecast and price target

Price $167.79 · data as of November 13, 2026

12-month price target

Average target$203.21
Upside / downside+21.1%
Analysts19
ConsensusBuy
Low $175.00Average $203.21High $235.00

Gold marker: average target · white marker: today’s price ($167.79)

Analyst ratings

Strong buy 3Buy 13Hold 4Sell 0Strong sell 0

Earnings and revenue estimates

PeriodEPS estimateEPS growthRevenue estimate
Current fiscal year
ends December 31, 2026
$2.07+21.2%$849M
Next fiscal year
ends December 31, 2027
$2.65+27.9%$1.1B
Next quarter
ends December 31, 2026
$0.52+6.9%$241M
Quarter after
ends March 31, 2027
$0.60+24.0%$250M

Consensus of the analysts covering Repligen, updated daily. In the last 30 days 8 estimates were raised and 5 lowered.

Our model vs. Wall Street

Analysts see 21.1% upside over 12 months. Our discounted cash flow model with moderate assumptions puts Repligen’s intrinsic value about 76% below today’s market value, and it scores 1.8 out of 5 on our checks. Price targets follow sentiment; a DCF follows cash. When both point the same way the signal is stronger. Try your own assumptions.

Frequently asked questions

What is the Repligen stock price target?

The average 12-month target from 19 analysts is $203.21, 21.1% above the current price of $167.79 Targets range from $175.00 to $235.00.

Is Repligen a buy according to analysts?

The consensus rating is “Buy” (3 strong buy, 13 buy, 4 hold). Ratings are opinions, not guarantees; this is not investment advice.

How much is Repligen expected to earn?

Analysts expect EPS of $2.07 for the fiscal year ending December 31, 2026 and $2.65 the year after.

Analyst consensus estimates and price targets, updated daily. Forecasts can be wrong; this is information, not investment advice.